This is a shared mechanism module, not a disease.
Disorder-specific substitutions at the trigger node: TGM1 (transglutaminase-1 cross-linking of the protein envelope), FLG (profilaggrin-derived keratin aggregation matrix), ALOX12B / ALOXE3 (the epidermal lipoxygenase pathway acting on the corneocyte lipid envelope), ABCA12 (lamellar-body glucosylceramide transporter), STS (steroid sulfatase; cholesterol sulfate accumulation), SPINK5 (LEKTI restraint of kallikrein-mediated desquamation), ALDH3A2 (Sjogren-Larsson fatty aldehyde dehydrogenase), ABHD5/PNPLA2 (Chanarin-Dorfman neutral lipid storage), and the distal cholesterol biosynthetic enzymes (CHILD/CDPX2/MSMO1 group).
Deliberately scoped to the cornification arm. Three related mechanisms are NOT re-derived here and have their own modules: dominant-negative keratin filament collapse (`keratin_intermediate_filament_fragility`, which the epidermolytic ichthyoses conform to *in parallel* with this module), desmosomal adhesion loss (`desmosomal_adhesion_failure`), and the type 2 allergic-sensitization arm of barrier loss (`epithelial_barrier_dysfunction`, which models where barrier failure leads *immunologically* rather than how cornification fails structurally). A filaggrin-deficient entry may reasonably conform to both this module and `epithelial_barrier_dysfunction`.
Not an Xogenesis module: the terminal output is the failure of a normal programmed process (cornification), not the formation of a new pathological anatomical entity.
Barrier failure is the intended conformance target because it is the node every route funnels through and the node topical therapy acts on. Attaching at the trigger node alone is insufficient for conformance - an entry must evidence the barrier consequence, not merely a mutation in a cornification gene.
Cornification Program Component Deficiency
trigger
A structural, enzymatic, or lipid-transport component required for terminal keratinocyte differentiation is deficient or absent. The affected component differs by disorder, but each is required for the orderly conversion of a granular-layer keratinocyte into a corneocyte.
Downstream
-
Defective Cornified Envelope Assembly and Lamellar Lipid Delivery
Loss of the deficient component prevents normal assembly of the cross-linked protein envelope, of the extracellular lipid lamellae, or of both.
Show evidence (2 references)
"The recent identification of genetic skin diseases with mutations in the genes encoding some of these proteins, including transglutaminase 1 and loricrin, has disclosed that abnormal cornified cell envelope synthesis is significantly involved in the pathophysiology of certain inherited keratodermas"
Establishes that loss of individual cornified-envelope components is the shared proximal lesion across several inherited disorders of cornification.
"An in situ TGase activity assay detected markedly reduced TGase activity in the patient's epidermis. Electron microscopy revealed incomplete thickening of the cornified cell envelope during keratinization in the epidermis."
Shows the trigger-to-amplifier step directly in patient epidermis: loss of transglutaminase-1 activity yields an incompletely assembled cornified envelope.
Defective Cornified Envelope Assembly and Lamellar Lipid Delivery
amplifier
The two structural arms of cornification fail. The insoluble, transglutaminase cross-linked protein envelope beneath the corneocyte plasma membrane is incompletely assembled, and/or lamellar bodies fail to deliver glucosylceramides and other lipid precursors to the extracellular space, so the intercellular lipid lamellar membrane of the stratum corneum is not formed. Either arm alone is sufficient to compromise the barrier; most disorders show some degree of both.
Downstream
-
Stratum Corneum Permeability Barrier Failure
An incomplete protein envelope and absent or disorganized intercellular lipid lamellae leave the stratum corneum permeable.
Show evidence (2 references)
"We confirmed that ABCA12 defects cause congested lipid secretion in cultured HI keratinocytes and succeeded in obtaining the recovery of LG lipid secretion after corrective gene transfer of ABCA12."
Demonstrates the lipid arm of this node and, via the gene-correction rescue, that lamellar-granule lipid secretion is the step ABCA12 controls.
"During terminal differentiation, it is cleaved into multiple filaggrin peptides that aggregate keratin filaments. The resultant matrix is cross-linked to form a major component of the cornified cell envelope."
Demonstrates the protein-envelope arm: profilaggrin-derived filaggrin supplies the keratin-aggregating matrix that is cross-linked into the cornified envelope.
Stratum Corneum Permeability Barrier Failure
central effector
The stratum corneum fails as a permeability barrier: transepidermal water loss rises and the epidermis is more permeable to the external environment. This is the rate-limiting, disorder-agnostic node of the module - every upstream route converges here, and it is the node topical barrier-repair therapy targets.
Downstream
-
Compensatory Epidermal Hyperproliferation and Retention Hyperkeratosis
Barrier failure signals a homeostatic repair response - increased lipid and DNA synthesis - while defective corneocyte shedding retains corneocytes at the surface.
Show evidence (2 references)
"In HI skin, loss of function of ABCA12 due to null mutations results in impaired lipid lamellar membrane formation in the cornified layer, leading to defective permeability of the skin barrier."
States the amplifier-to-central-effector step explicitly: failed lamellar membrane formation produces permeability barrier failure.
"New insights into the molecular mechanisms and the physiological endpoints of cornification are increasing our understanding of the pathological defects of this unique form of programmed cell death, which is associated with barrier malfunctions and ichthyosis."
Ties defective cornification to barrier malfunction and to ichthyosis as a disease class, supporting this node as the shared convergence point.
Compensatory Epidermal Hyperproliferation and Retention Hyperkeratosis
effector
Two processes thicken the stratum corneum. First, barrier disruption stimulates epidermal DNA synthesis and hyperplasia as a homeostatic attempt to restore the barrier. Second, corneocyte shedding is impaired, so corneocytes are retained rather than desquamated. Disorders differ in which process dominates - retention hyperkeratosis is the primary mechanism in X-linked ichthyosis, whereas hyperproliferative kinetics predominate in the congenital ichthyosiform erythrodermas.
Downstream
-
Ichthyotic Scaling and Cutaneous Barrier Complications
A thickened, poorly shed stratum corneum presents clinically as adherent scale, and the underlying barrier defect produces its systemic complications.
Show evidence (2 references)
"After barrier disturbance not only lipid but also DNA synthesis is stimulated. Stimulation of DNA synthesis leading to epidermal hyperplasia may be a second mechanism by which the epidermis tries to correct defects in barrier function."
Establishes the central-effector-to-effector step: barrier disruption is itself the signal that drives compensatory epidermal hyperproliferation.
"Affected patients can normally produce skin cells but cannot shed them correctly, leading to dry skin that accumulates in the form of polygonal scales."
Documents the retention-hyperkeratosis arm of this node in X-linked ichthyosis, where impaired shedding rather than hyperproliferation dominates.
Ichthyotic Scaling and Cutaneous Barrier Complications
consequence
The clinical endpoint: generalized adherent scaling, with disorder-dependent erythroderma, palmoplantar keratoderma, and fissuring. Because the defect is a permeability barrier defect and not merely a cosmetic one, severe forms carry neonatal transcutaneous water and electrolyte loss, impaired thermoregulation, and increased cutaneous infection risk.
Show evidence (2 references)
"Mutations in genes encoding transglutaminase 1 (TGM1), the ABCA12 transporter (ABCA12), ichthyin, lipoxygenase 3 (ALOXE3), and 12(R)-lipoxygenase (ALOX12B) have been shown to underlie both NBCIE and LI."
Shows that mechanistically distinct upstream lesions produce the same clinical scaling endpoint, which is the convergence this module asserts.
"X-linked ichthyosis is a genetic disorder of keratinization characterized by a generalized desquamation of large, adherent, dark brown scales."
Characterizes the scaling endpoint reached through the steroid-sulfatase route.